U.S. equity futures rose on Wednesday with the Dow Jones Industrial average set to gain for a third day after news of an effective Pfizer Covid-19 vaccine earlier this week sparked hopes of a return to normal economic activity.

Futures for the 30-stock index galloped 217 points, or 0.7%, to 29,520.

Futures for the S&P 500 acquired 28.75 points, or 0.8%, at 3,569.75.

Futures for the NASDAQ Composite jumped 139 points, or 1.2%, to 11,757.25.

Tech stocks made their way back upward. Alphabet and Microsoft both traded 1% higher in the pre-market. Apple gained 0.9%. Netflix climbed 0.6%. Facebook and Amazon rose 0.7% each.

Eli Lilly’s antibody drug was cleared by the Food and Drug Administration for emergency use late Monday. The agency said the drug could be used to treat mild-to-moderate cases of Covid-19 in patients who are older than 12 years old.

The vaccine and antibody drug news comes as the United States once again topped its prior day record of daily new Covid-19 infections, on a seven-day average, while also crossing the bleak milestone of more than 10 million cases nationwide on Monday.

The seven-day average of daily new cases Monday was 108,964, a 37% increase from a week ago, according to an analysis of data from Johns Hopkins University.

The energy sector is up 17% this week, as oil prices gain on hopes of improving demand. The financial sector has risen about 9% since Monday.

Overseas, in Japan, the Nikkei 225 index rocketed 1.8%, while in Hong Kong, the Hang Seng index slid 0.3%.

Oil prices added $1.02 to $42.38 U.S. a barrel.

Gold prices toppled $7.50 to $1,868.90.